Integral Derivatives’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-80,400
Closed -$748K 1317
2016
Q4
$748K Buy
80,400
+28,800
+56% +$298K 0.01% 596
2016
Q3
$546K Buy
51,600
+5,000
+11% +$49.8K 0.01% 606
2016
Q2
$435K Buy
46,600
+14,300
+44% +$145K 0.01% 641
2016
Q1
$336K Sell
32,300
-285,700
-90% -$2.61M 0.01% 613
2015
Q4
$3.2M Buy
318,000
+42,000
+15% +$421K 0.08% 188
2015
Q3
$2.32M Buy
276,000
+150,000
+119% +$1.99M 0.06% 260
2015
Q2
$2.03M Buy
+126,000
New +$1.96M 0.06% 313

Other funds holding OPK

Integral Derivatives's OPK Position: Q1 2018 in Review

Integral Derivatives sold out of Opko Health (OPK) in Q1 2018, closing a stake of 20,007 shares — an estimated $98K sold.

Integral Derivatives first reported a position in OPK in Q4 2013 and held it in 6 quarters. The position peaked at $5.08M in Q2 2015. 227 funds tracked by Wall St. Rank hold OPK as of Q1 2018.

  • Integral Derivatives reported no remaining Opko Health position as of Q1 2018 after selling out during the quarter.
  • Integral Derivatives sold 20,007 Opko Health shares in Q1 2018, an estimated $98K.
  • Integral Derivatives first reported a position in Opko Health in Q4 2013 and held it in 6 quarters.
  • Integral Derivatives's Opko Health position peaked at $5.08M in Q2 2015.
  • 227 funds tracked by Wall St. Rank held Opko Health as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.